Nicotine use and its correlates in patients with psychosis

Acta Psychiatrica Scandinavica - Tập 116 Số s435 - Trang 27-32 - 2007
Sten Levander1, Jakob Eberhard, Eva Lindström
1Department of Health and Society, Malmö University, Malmö, Sweden

Tóm tắt

Objective:  To examine nicotine use and its correlates among psychotic patients.Method:  Longitudinal naturalistic study of 176 patients, diagnosed with schizophrenia or schizophrenia‐related psychotic disorders, and treated with risperidone at study entry. Levels of nicotine use (smoking, snuffing) were measured along with other relevant ratings and measurements (symptoms, drug treatment, side effects, weight, cognitive functions and outcome) at baseline and once yearly for 5 years.Results:  Nicotine use was twice as common as in the general population. Only few nicotine users had started after onset of psychoses. We could not find any differences among nicotine users and non‐users in diagnosis, symptoms, side effects, weight, cognitive functions, personality and outcome, cross‐sectionally and longitudinally, ruling against the ‘self‐medication’ hypothesis.Conclusion:  A parsimonious interpretation of the findings is that patients suffering from psychosis fail to desist from nicotine rather than experience significant positive effects of the usage.

Từ khóa


Tài liệu tham khảo

10.1016/j.schres.2005.02.010

10.1176/ajp.155.11.1490

10.1097/00005053-200209000-00005

10.1016/j.neubiorev.2005.02.006

10.1111/j.1600-0447.2005.00540.x

10.1111/j.1600-0447.2005.00539.x

10.1111/j.1600-0447.2004.00293.x

10.1001/archpsyc.62.6.649

10.1038/sj.npp.1300881

American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders (DSM‐IV)

10.1192/bjp.186.3.215

10.1016/j.addbeh.2004.04.012

10.1016/j.eurpsy.2004.09.005

10.1111/j.1600-0447.2007.01083.x

10.1093/schbul/13.2.261

Chouinard G, 1980, The extrapyramidal symptom rating scale, Can J Neurol Sci, 7, 233

10.1001/archpsyc.1982.04290040080014

10.1080/080394801317084428

Guy W, 1976, ECDEU Assessment manual for psychopharmacology – revised (DHEW Publ ADM 76‐338), 534

10.1001/archpsyc.1972.01750300011002

10.1111/j.1600-0447.2006.00899.x

Eberhard J, 2003, Premorbid IQ and schizophrenia – increasing cognitive reduction by episodes, Eur Arch Psy Clin Neurosci, 253, 84, 10.1007/s00406-003-0412-y

10.1034/j.1600-0447.2000.102003217.x

10.1016/j.addbeh.2006.06.016

10.1016/j.drugalcdep.2006.06.005

10.1038/sj.npp.1300450

10.1016/j.psychres.2004.05.021

10.1016/S0920-9964(99)00191-7

10.1111/j.1600-0447.2004.00372.x

10.1111/j.1600-0447.2006.00850.x